No headlines found.
No press releases found.
No news found.
Drugs Made In America Acquisition Corp. - Units trades on the stock market under the symbol DMAAU.
As of August 3, 2026, DMAAU stock price was flat at $10.97 with million shares trading.
DMAAU has a market cap of $0.00. This is considered a Sub-Micro Cap stock.
DMAAU has underperformed the market in the last year with a price return of +4.9% while the SPY ETF gained +23.1%. DMAAU has also underperformed the stock market ETF in the last 3 month and 2 week periods returning +2.6% and -0.2%, respectively, while the SPY returned +5.4% and +2.1%, respectively.
DMAAU support price is $10.85 and resistance is $11.09 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that DMAAU shares will trade within this expected range on the day.
